Navigation Links
ImClone in Medical News

Lilly Files Form 8-K/A Detailing Pro Forma Impact of ImClone Acquisition

INDIANAPOLIS, Jan. 12 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) today filed a Form 8-K/A with the U.S. Securities and Exchange Commission (SEC) detailing the pro forma impact of the company's recently- completed acquisition of ImClone Systems. The Form 8-K/A is available o...

Lilly Completes Acquisition of ImClone Systems

INDIANAPOLIS, Nov. 24 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) today announced that it has completed its acquisition of ImClone Systems Incorporated. ImClone Systems is now a wholly-owned subsidiary of Lilly. "We are excited about the successful completion of the ImC...

Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance

...d in the reconciliation tables and also assume the imclone acquisition was completed January 1, 2008. The pro...he inclusion of Erbitux revenue as a result of the imclone acquisition. U.S. total revenue increased 12 perce... expenses in the U.S., offset by the impact of the imclone acquisition and increased Effient pre-launch activ...

Icahn Issues Open Letter to Amylin Shareholders

...cize Dr. Alexander Denner's tenure on the board of imclone and as Chairman of the Executive Committee and my ... little interest in the Company. Most importantly, imclone had failed to realize the potential of its signifi...enda of all corporate directors. In recent memory, imclone is the only public company that has been sold whil...

Celator(R) Pharmaceuticals Presents New Data on CPX-351 And CPX-1 at the American Association for Cancer Research

... (Hall B-F, Poster Section 33, Poster Board 11). Avastin(R) is a registered trademark of Genentech Inc. Erbitux(R) is a registered trademark of imclone Systems Incorporated ...

Icahn Responds to Cook and Wilson

...ested $300 million into the company and received $1.3 billion. I also sold imclone for $70 per share (which I had accumulated at an average cost of about $33 per share). I negotiated that $70 per share price after urging that imclone turn down an unsolicited bid in the high $30's and even the Bristol $60 and...

Lilly Reports Strong First-Quarter 2009 Results

...d in the reconciliation tables and also assume the imclone acquisition was completed January 1, 2008. The pro...ng to $.05 per share. To reflect the impact of the imclone acquisition as if the acquisition occurred in Janu...d earnings per share by $.19. Assuming the imclone acquisition was completed on January 1, 2008, the ...

Letter From Carl Icahn to Amylin Pharmaceutical, Inc.

...ders and based upon the experiences that I and my suggested nominees had in imclone Systems, I believed it would be in Amylin's best interest to give these nom...alue at ImClone. As you may be aware, after I was elected to the board of imclone in October 2006, its per share market value increased by 135% through its s...

Lori Hamilton, Wife of NASCAR Legend Bobby Hamilton, Urges Public to Attend Free Cancer Screenings During Oral, Head & Neck Cancer Awareness Week (OHANCAW)

...ation, please visit the OHANCAW website at www.OHANCAW.com . Funding for the OHANCAW free screenings was provided by Bristol-Myers Squibb and imclone Systems, a wholly-owned subsidiary of Eli Lilly and Company. Media Contact: Jennifer McGuire or Alanna Jamieson MCS Healthcare Pub...

Lilly Reports Fourth-Quarter and Full-Year 2008 Results

...AAP basis. Pro forma non-GAAP guidance assumes the imclone acquisition was completed on January 1, 2008. ...es of $4.730 billion related to the acquisition of imclone Systems. -- Primarily as a result of the imclone acquisition charges, the company reported a net lo...
ImClone in Medical Technology

Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal Antibody IMC-A12 Presented at ASCO

NEW YORK--(BUSINESS WIRE)--Jun 5, 2007 - First-in-human results for IMC-A12, a monoclonal antibody developed by ImClone Systems Incorporated (NASDAQ: IMCL) and targeted to IGF-1R (insulin-like growth factor type 1 receptor), were presented at the annual meeting of the American Society of Clinical O...

Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs

...ne's Research Division including approximately 125 imclone scientists with plans to add scientists in those areas that support expansion of the imclone pipeline. The new location enables unprecedented ...of innovation, Lilly also said that it now has six imclone molecules in its pipeline, bringing the company's ...

Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies

...ic colorectal cancer," (abstract 3512) represents the first publicly presented results of Genomic Health's collaboration with Bristol-Myers Squibb and imclone Systems Incorporated for ERBITUX (cetuximab), a targeted therapy for colon cancer. Researchers analyzed formalin-fixed, paraffin-embedded tumor samp...

New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer

...es - NEW YORK, Nov. 14 /PRNewswire-FirstCall/ -- imclone Systems Incorporated (Nasdaq: IMCL ) and Bristol-...Chief Medical Officer and Senior Vice President of imclone Systems. "These data demonstrate that ERBITUX may...other (27%, 6%), and stomatitis (25%, 10%). About imclone Systems ...

Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer

... NEW YORK, Oct. 2 /PRNewswire-FirstCall/ -- imclone Systems Incorporated (Nasdaq: IMCL ) and Bristol-...Chief Medical Officer and Senior Vice President of imclone Systems. "This approval for ERBITUX as a monothera...other (27%, 6%), and stomatitis (25%, 10%). About imclone Systems ...

ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study

... NEW YORK, Sept. 11 /PRNewswire-FirstCall/ -- imclone Systems Incorporated (Nasdaq: IMCL ) and Bristol-...al conference. Merck KGaA, Darmstadt, Germany, is imclone Systems' ERBITUX partner outside of North America....tipation (30%/26%), and headache (14%/26%). About imclone Systems ...

Survival Data Available from Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer

... NEW YORK--(BUSINESS WIRE)--Apr 4, 2007 - imclone Systems Incorporated (NASDAQ: IMCL) and Bristol-My...ipation (30%/26%), and headache (14%/26%). About imclone Systems imclone Systems Incorporated is committed to advancing onc...

Survival Data Available From Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer

...ipation (30%/26%), and headache (14%/26%). About imclone Systems imclone Systems Incorporated is committed to advancing onc...nt programs from the research stage to the market. imclone Systems' headquarters and research operations are ...

Data Available from Erbitux Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer

...Chief Medical Officer and Senior Vice President of imclone Systems. "We still consider pancreatic cancer to b... constipation (30%/26%), and headache (14%/26%). imclone Systems Incorporated is committed to advancing onc...nt programs from the research stage to the market. imclone Systems' headquarters and research operations are ...

Randomized Phase III Trial Showed Erbitux Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients

...Chief Medical Officer and Senior Vice President of imclone Systems. "We believe these outcomes add to the exi...ipation (30%/26%), and headache (14%/26%). About imclone Systems imclone Systems Incorporated is committed to advancing onc...
ImClone in Medical Dictionary

Circadian

...rhythms is called chronobiology. ... Circadian granted key strategic VEGF-D patent in Europe for angiogenic applications ... Circadian partner imclone Systems demonstrates VEGFR-3 antibody improves anti ... ...
ImClone in Biological Technology

Lilly Completes Cash Tender Offer for ImClone Systems

INDIANAPOLIS and New York, Nov. 21 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) and ImClone Systems Incorporated (Nasdaq: IMCL ) today announced the successful completion of the previously announced tender offer by Lilly's wholly-owned subsidiary, Alaska Acquisition Corporation...

Lilly Commences Cash Tender Offer for ImClone Systems at $70 Per Share

INDIANAPOLIS, Oct. 14 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) announced today that its wholly-owned subsidiary, Alaska Acquisition Corporation, has commenced its tender offer for all outstanding shares of ImClone Systems Incorporated (Nasdaq: IMCL ) at a price of $70.00 ...

Lilly to Acquire ImClone Systems in $6.5 Billion Transaction

Creates a Global Leader in Oncology Biopharmaceuticals Boosts Oncology Pipeline With Up to Three Promising Targeted Therapies in Phase III in 2009 INDIANAPOLIS and NEW YORK, Oct. 6 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) and ImClone Sys...

Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs

ARLINGTON, Va., May 7 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced that it has established an agreement ...

Alexandria Real Estate Equities, Inc. Signs Biopharmaceutical Company, Lilly, as Anchor New York City Tenant at the Alexandria Center for Science and Technology

...hich will become the new research headquarters for imclone Systems, a wholly-owned subsidiary of Eli Lilly an... Larry Witte, Senior Vice President of Research of imclone Systems and Joel S. Marcus, Chairman, President an...ities, Inc., as well as many dignitaries. imclone Systems is a leader in the development and commerc...

Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results

...e of the net gain of $40,170,000 from the settlement of our litigation with imclone Systems, for fiscal year 2008. This increase in operating expenses of $1,9...one time net gain of $40,170,000 from the settlement of our litigation with imclone Systems. Cash, cash equivalents and marketable securities as of March 31, ...

Senesco Technologies, Inc. Announces the Appointment of Dr. Harlan W. Waksal, M.D. as Chairman of the Board of Directors and the Addition of Mr. Warren J. Isabelle, CFA to its Board of Directors

... in October 2008. Dr. Waksal is President and sole Proprietor of Waksal Consulting L.L.C. in Montclair, NJ. From 1984 through July 2003, he was with imclone Systems Inc., New York, NY, serving most recently as President, Chief Executive Officer and Chief Operating Officer. Dr. Waksal is a member of th...

Lilly Set to Unveil More Than 50 Studies at ASCO 2009

... This year's ASCO also marks the first time Lilly will feature the newest molecules in its portfolio resulting from Lilly's recent acquisition of imclone Systems. "ASCO's theme of 'Personalizing Cancer Care' is one to which Lilly has subscribed for many years," said Richard Gaynor, M.D., Lilly vic...

ImClone Systems and Lonza Walkersville to Discuss Paperless QC Micro at PDA Annual Meeting

...s, Supervisor, QC Microbiology Laboratory Systems, imclone Systems. 8:30 - 9:00 am: Improvement in QC Envi...perless solution," explains Robert Lutskus at imclone Systems. "The wide varieties of reports allow...ess and attendees can have direct discussions with imclone Systems and Lonza Walkersville. To learn more ...

Stephen H. Friend, MD, PhD to Keynote at Defined Health's 9th Annual Therapeutic Insight Conference

...ab, Inc. Dennis J. Purcell, MBA, Senior Managing Partner, Aisling Capital, LLC Eric Rowinsky, MD, EVP & Chief Medical Officer, imclone Edward C. Saltzman, President, Defined Health William K. Schmidt, PhD, President, NorthStar Consulting, LLC Paul J. Sekh...
Other Tags
(Date:12/26/2014)... (PRWEB) December 26, 2014 It is said ... great dress. Today, UWDress.com, the famous wedding dress supplier, ... launches a site-wide cocktail gown promotion. , UWDress.com’s navy ... collection, and they come in high fashion styles. Simple dresses ... depending on the occasion; they are specially designed for those ...
(Date:12/26/2014)... 26, 2014 “Many people become overwhelmed ... injury claim issues and phone calls with insurance companies,” ... article featuring their free eBook on pedestrian and ... on pedestrian and bicycle auto accident claims assures the ... capable of professionally handling their case while they focus ...
(Date:12/25/2014)... 26, 2014 The microscopy market ... 7.2% to reach $5,756.0 million by 2019. Optical ... market. The electron microscopes product segment is expected ... period. , Rising focus on nanotechnology, technological advancements, ... the microscopy market. , Get Full Copy of ...
(Date:12/25/2014)... York (PRWEB) December 25, 2014 Product ... DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to ... According to an Order issued in the U.S. District ... Court will convene an open conference on January 7, ... United States Courthouse in West Palm Beach, Florida. The ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 Recently, ... discounts on all its wedding dresses. BellasDress has chosen ... more for gift choices for the holiday season. ... can pick suitable wedding gowns here at discount prices. ... shopping experience at its website. , “All ...
Breaking Medicine News(10 mins):Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2
(Date:12/10/2014)... , Dec. 08, 2014 Research and Markets ... addition of the "Biometrics Market in Japan ... http://photos.prnewswire.com/prnh/20130307/600769 The ... such as rural banking and upgradation of the ... witnessed in the market. Besides the aforementioned projects, ...
(Date:12/5/2014)... , Dec. 4, 2014  Tute Genomics, a leader ... million in Series A1 funding led by UK-based Eurovestech. ... participated in the investment round. "We are ... community adopts next-generation sequencing and seeks new approaches for ... Reid Robison , MD MBA, and CEO of Tute ...
(Date:12/3/2014)... 2, 2014 As part of our commitment ... is pleased to announce the release of a new ... collect the workforce data that they need. ... left by existing readers. Many such devices have serious ... modern technology. Older models force users to navigate numerous ...
Breaking Biology News(10 mins):Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Inception Technologies to Release New Biometric Reader 2
Other Contents